ArticleTherapeutic innovation & regulatory science2026
Challenges in Conducting Quantitative Patient-Centered Benefit-Risk Assessments: A Case Study in Ph + ALL with Immature Efficacy Data.
Ajibade Ashaye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.